The level of the soluble form of Fas, sFas (a receptor antagonist for the proapoptotic protein Fas [55]), in sera from affected patients is higher than the one of normal volunteers in idiopathic pulmonary fibrosis [56] and silicosis [57]. This evidence concerns the gene FAS and pulmonary fibrosis.